207 related articles for article (PubMed ID: 15311109)
1. Renal endothelin receptor type B upregulation in rats with low or high renin hypertension.
Brakch N; Abdel-Sayed S; Allemandou F; Wang Q; Aubert JF; Brunner HR; Nussberger J
J Hypertens; 2004 Sep; 22(9):1797-803. PubMed ID: 15311109
[TBL] [Abstract][Full Text] [Related]
2. Direct measurements of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alteration in salt-induced hypertension.
Hirata Y; Hayakawa H; Suzuki E; Kimura K; Kikuchi K; Nagano T; Hirobe M; Omata M
Circulation; 1995 Feb; 91(4):1229-35. PubMed ID: 7850963
[TBL] [Abstract][Full Text] [Related]
3. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
[TBL] [Abstract][Full Text] [Related]
4. Role of Brain Endothelin Receptor Type B (ET
Cassinotti L; Guil M; Bianciotti L; Vatta M
Curr Vasc Pharmacol; 2023; 21(4):246-256. PubMed ID: 37349999
[TBL] [Abstract][Full Text] [Related]
5. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
Allcock GH; Venema RC; Pollock DM
Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
[TBL] [Abstract][Full Text] [Related]
6. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
Schiffrin EL; Turgeon A; Deng LY
Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
[TBL] [Abstract][Full Text] [Related]
7. Renoprotective effects of a combined endothelin type A/type B receptor antagonist in experimental malignant hypertension.
Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Ueda M; Tatsumi Y; Yoshikawa J
Metabolism; 1997 Sep; 46(9):1032-8. PubMed ID: 9284892
[TBL] [Abstract][Full Text] [Related]
8. Renal damage is not improved by blockade of endothelin receptors in primary renin-dependent hypertension.
Rothermund L; Kossmehl P; Neumayer HH; Paul M; Kreutz R
J Hypertens; 2003 Dec; 21(12):2389-97. PubMed ID: 14654760
[TBL] [Abstract][Full Text] [Related]
9. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats.
David FL; Carvalho MH; Cobra AL; Nigro D; Fortes ZB; Rebouças NA; Tostes RC
Hypertension; 2001 Sep; 38(3 Pt 2):692-6. PubMed ID: 11566958
[TBL] [Abstract][Full Text] [Related]
10. Increased renal medullary endothelin-1 synthesis in prehypertensive DOCA- and salt-treated rats.
Hsieh TJ; Lin SR; Lee YJ; Shin SJ; Lai YH; Hsu CH; Tsai JH
Am J Physiol Renal Physiol; 2000 Jul; 279(1):F112-21. PubMed ID: 10894793
[TBL] [Abstract][Full Text] [Related]
11. Central endothelin ET
Guil MJ; Soria C; Seijas M; Bianciotti LG; Vatta MS
Eur J Pharmacol; 2020 Oct; 885():173543. PubMed ID: 32896551
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats.
Pollock DM; Allcock GH; Krishnan A; Dayton BD; Pollock JS
Am J Physiol Renal Physiol; 2000 Feb; 278(2):F279-86. PubMed ID: 10662732
[TBL] [Abstract][Full Text] [Related]
13. Involvement of endothelins in deoxycorticosterone acetate-salt hypertension through the modulation of noradrenergic transmission in the rat posterior hypothalamus.
Abramoff T; Guil MJ; Morales VP; Hope SI; Höcht C; Bianciotti LG; Vatta MS
Exp Physiol; 2015 Jun; 100(6):617-27. PubMed ID: 25809871
[TBL] [Abstract][Full Text] [Related]
14. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Li JS; Turgeon A; Schiffrin EL
Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
[TBL] [Abstract][Full Text] [Related]
15. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
Fujita K; Matsumura Y; Miyazaki Y; Hashimoto N; Takaoka M; Morimoto S
Life Sci; 1996; 58(1):PL1-7. PubMed ID: 8628104
[TBL] [Abstract][Full Text] [Related]
16. Role of ET-1 receptor binding and [Ca(2+)](i) in contraction of coronary arteries from DOCA-salt hypertensive rats.
Giulumian AD; Molero MM; Reddy VB; Pollock JS; Pollock DM; Fuchs LC
Am J Physiol Heart Circ Physiol; 2002 May; 282(5):H1944-9. PubMed ID: 11959662
[TBL] [Abstract][Full Text] [Related]
17. Decreased endothelin binding and [Ca2+]i signaling in microvessels of DOCA-salt hypertensive rats.
Molero MM; Giulumian AD; Reddy VB; Ludwig LM; Pollock JS; Pollock DM; Rusch NJ; Fuchs LC
J Hypertens; 2002 Sep; 20(9):1799-805. PubMed ID: 12195122
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan.
Larivière R; Sventek P; Thibault G; Schiffrin EL
Can J Physiol Pharmacol; 1995 Mar; 73(3):390-8. PubMed ID: 7544236
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
Callera GE; Tostes RC; Yogi A; Montezano AC; Touyz RM
Clin Sci (Lond); 2006 Feb; 110(2):243-53. PubMed ID: 16271043
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension.
Li L; Fink GD; Watts SW; Northcott CA; Galligan JJ; Pagano PJ; Chen AF
Circulation; 2003 Feb; 107(7):1053-8. PubMed ID: 12600921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
